Evidence map›Paper›PMID 41742050›Full record

ArticleMolecular medicine (Cambridge, Mass.)2026

Retraction Note: Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice.

Fausto Chiazza, Aurélie Couturier-Maillard, Elisa Benetti, Raffaella Mastrocola, Debora Nigro, Juan C Cutrin, Loredana Serpe, Manuela Aragno, Roberto Fantozzi, Bernard Ryffel and 2 more

Abstract readRetraction Notice
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Fausto ChiazzaDipartimento di Scienza e Tecnologia del Farmaco, Università di Torino, via P. Giuria 9, Torino, 10125, Italy.
Aurélie Couturier-MaillardImmunologie et Neurogénétique Expérimentales et Moléculaires, CNRS, UMR7355 INEM, University of Orléans, Orléans, France.
Elisa BenettiDipartimento di Scienza e Tecnologia del Farmaco, Università di Torino, via P. Giuria 9, Torino, 10125, Italy.
Raffaella MastrocolaDipartimento di Scienze Cliniche e Biologiche, Università di Torino, Turin, Italy.
Debora NigroDipartimento di Scienze Cliniche e Biologiche, Università di Torino, Turin, Italy.
Juan C CutrinDipartimento di Biotecnologie Molecolari e Scienze per la Salute, Università di Torino, Turin, Italy.
Loredana SerpeDipartimento di Scienza e Tecnologia del Farmaco, Università di Torino, via P. Giuria 9, Torino, 10125, Italy.
Manuela AragnoDipartimento di Scienze Cliniche e Biologiche, Università di Torino, Turin, Italy.
Roberto FantozziDipartimento di Scienza e Tecnologia del Farmaco, Università di Torino, via P. Giuria 9, Torino, 10125, Italy.
Bernard RyffelImmunologie et Neurogénétique Expérimentales et Moléculaires, CNRS, UMR7355 INEM, University of Orléans, Orléans, France.
Christoph ThiemermannCentre for Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Massimo CollinoDipartimento di Scienza e Tecnologia del Farmaco, Università di Torino, via P. Giuria 9, Torino, 10125, Italy. massimo.collino@unito.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41742050
PMCPMC12934075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.